Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-057678
Filing Date
2025-12-17
Accepted
2025-12-17 16:43:02
Documents
1
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1766007778.html 4  
1 FORM 4 wk-form4_1766007778.xml 4 7412
  Complete submission text file 0001628280-25-057678.txt   8918
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
McNeill Jonathan (Reporting) CIK: 0001824673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 251579878